Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05694793 · ClinicalTrials.gov registry record · NA

Trial for Reliability of Urodynamics SysTem

A NA study of Urologic Diseases and Urodynamics, sponsored by Bright Uro.

Recruiting
Registry status
NA
Development phase
28
Enrollment target
4
Study locations

NCT05694793 is a NA study of Urologic Diseases and Urodynamics that is actively recruiting participants, run by Bright Uro. The registered enrollment target is 28 participants, below the 118-participant average among 11 other Urologic Diseases trials with a reported enrollment target (76% lower). The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05694793, a NA study of Urologic Diseases and Urodynamics, is actively recruiting participants, sponsored by Bright Uro.

RECRUITING
Registry status
NA
Development phase
28 participants
Enrollment target
4
Study locations

Study Summary

The goal of this prospective trial is to assess the safety and reliability of the Glean Urodynamics System (GUS) in adult females with lower urinary tract symptoms. The main question\[s\] it aims to answer are: • What is GUS's ability to safely and reliably conduct wireless, catheter-free monitoring of vesical pressure compared to the vesical pressures collected with conventional urodynamics? Participants will undergo a conventional urodynamics exam, a simultaneous urodynamics exam with GUS, ambulatory urodynamics with GUS, and extended home monitoring with GUS. Researchers will compare GUS data with that from a conventional urodynamics exam.

Interventions

  • DEVICE Glean Urodynamics System

Study Locations (4)

California

  • Tri Valley Urology Medical Group - Murrieta
  • University of California San Diego - San Diego
  • Unio Health Partners - Torrence

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2025-06-03
Est. Completion 2026-07
Phase NA

Sponsor

Bright Uro

5 total trials

What the Registry Record Tells You About NCT05694793

The ClinicalTrials.gov registry entry for NCT05694793 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 118-participant average among 11 other Urologic Diseases trials with a reported enrollment target (76% lower). The listed sponsor is Bright Uro, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Urologic Diseases appearing as the primary indexed condition, and to 1 intervention - of which Glean Urodynamics System is the first listed.

NCT05694793 reports 4 study locations spanning 2 distinct geographic areas - top geographies include California, Ohio.

Frequently Asked Questions

What is clinical trial NCT05694793 about?

NCT05694793 is a clinical study titled "Trial for Reliability of Urodynamics SysTem". The goal of this prospective trial is to assess the safety and reliability of the Glean Urodynamics System (GUS) in adult females with lower urinary tract symptoms. The main question\[s\] it aims to answer are: • What is GUS's ability to safely and reliably conduct wireless, catheter-free monitorin...

What is the current status of trial NCT05694793?

This trial is currently recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2025-06-03. Estimated completion is 2026-07.

What conditions does trial NCT05694793 study?

This clinical trial studies the following conditions: Urologic Diseases, Urodynamics.

What interventions are being tested in trial NCT05694793?

The interventions under investigation include: Glean Urodynamics System (DEVICE).

Who is sponsoring clinical trial NCT05694793?

This trial is sponsored by Bright Uro, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05694793 being conducted?

This trial has 4 study locations across California, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urologic Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.